iPASy Technologies

iPASy Technologies is a Veszprém-based medical technology startup established in 2023 that focuses on advancing prostate cancer diagnostics. The company has developed a non-invasive, urine-based diagnostic procedure that utilizes advanced PSA glycosylation pattern analysis. This method is designed to improve diagnostic accuracy, reduce false-positive rates compared to conventional serum PSA tests, and decrease the necessity for unnecessary biopsies. The technology is supported by research originating from a Ph.D. program and has reached the preliminary examination stage of patent application, with clinical trials initiated in Germany.

By providing a more reliable and cost-effective screening solution, iPASy Technologies aims to redefine the standard of care for prostate cancer diagnostics. The startup, which employs a small team, is actively working toward CE marking for its diagnostic kit to streamline the screening process and offer more comprehensive clinical insights. The company has showcased its developments at international industry events, such as MEDICA, to engage with partners and medical professionals in the field of clinical diagnostics.